Bevacizumab

  • Humanized monoclonal antibody to Vascular endothelial growth factor
  • (VEGF) receptors 1 and 2

  • Intravenous

* For further reading refer to a pharmacology source

  • Anti-vascular endothelial growth factor (VEGF) receptors 1 & 2

  • Mainly used in cancer treatment

Off label (dermatologic):

  • Psoriasis (1 study)

* For further reading refer to a pharmacology source

  • Stomatitis
  • Mucosal bleeding
  • Impaired wood healing

* For further reading refer to a pharmacology source

  • Single report of use in Psoriasis